In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

The free consultation period for this content is over.

It is now only available year-round to EAPC Ivory (& above) Members, Fellows of the ESC and Young combined Members

Setting up a smoking cessation service - what can we expect from the first year?

Session Poster Session III - Friday 08:30 - 12:30

Speaker Thilo Burkard

Event : ESC Preventive Cardiology (Formerly EuroPrevent) 2015

  • Topic : preventive cardiology
  • Sub-topic : Tobacco
  • Session type : Poster Session

Authors : D Schneider (Basel,CH), A Meienberg (Basel,CH), A Deman (Basel,CH), T Burkard (Basel,CH)

D Schneider1 , A Meienberg1 , A Deman1 , T Burkard1 , 1University Hospital Basel - Basel - Switzerland ,


Purpose: According to the WHO, smoking is the single most important preventable cause for premature death worldwide. Since different guidelines support to offer specialised tobacco treatment programs to smokers, we started a physician-led smoking cessation service (SCS) at a tertiary university hospital in 2012. SCS consultations on an individual basis were done by junior-physicians, supervised by senior physicians with special interest in smoking cessation. The present study presents our results of the first year of the SCS according to self-reported quit-rate and patient satisfaction.
Methods: In this cross-sectional study we included all patients (pts) consulting our SCS between 1.6.2012 – 31.5.2013. Baseline and treatment characteristics were obtained from pts charts. Pts were contacted by telephone or if not possible by letter for a standardized interview or questionnaire in February 2014 and self-reported smoking status and satisfaction with consultations (0=low, 10=high) were asked.
Results: 80 pts had their first SCS consultation during the first year. Follow-up (FU) data could be obtained from 68 pts, the remaining 12 were considered to be smokers. Mean FU was 430±95 days after their first SCS consultation. 41% of pts were male, mean age was 54±12 years, median Fagerström Dependency Level was 5 [4-7], 79% of pts had at least 1 smoking-associated comorbidity. Mean number of consultations was 2.9±2.3. 28.8% of all pts reported to be persistent abstinent (PA) over the past 7 days. Factors associated with PA were number of consultations and use of vareniclin.  Comparing pts with =2 vs. >2 consultations PA rates were 20% vs. 40% (p=0.05).  Median patient satisfaction was 8 [6-10], with 86.8% of pts stating that they would recommend the SCS to other smokers.
Conclusion: Our results show, that it is feasible to achieve persistent abstinence rates of 30% after a mean FU of 61 weeks and a high patient acceptance of the SCS - even in the first year. Our outcome in real-life pts is comparable to results of smoking cessation trials and could encourage further centers to set up a SCS.

Members get more

Join now
  • 1ESC Professional Members – access all resources from general ESC events 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are